These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30108439)

  • 1. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 predicts poor prognosis in hepatocellular carcinoma.
    Chen W; Fu Q; Fang F; Fang J; Zhang Q; Hong Y
    Saudi J Biol Sci; 2018 Jul; 25(5):904-908. PubMed ID: 30108439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition.
    Liu J; Yu GZ; Cheng XK; Li XD; Zeng XT; Ren XQ
    Oncotarget; 2017 Aug; 8(31):50896-50903. PubMed ID: 28881613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
    Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
    Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
    Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
    Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma.
    Effendi K; Yamazaki K; Fukuma M; Sakamoto M
    Liver Cancer; 2014 Oct; 3(3-4):451-7. PubMed ID: 26280006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells.
    Fukuma M; Tanese K; Effendi K; Yamazaki K; Masugi Y; Suda M; Sakamoto M
    Exp Cell Res; 2013 Feb; 319(3):113-21. PubMed ID: 23127514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
    BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
    Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
    Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
    Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
    BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma.
    Ashizawa Y; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Hepatol Commun; 2019 Jul; 3(7):954-970. PubMed ID: 31304451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma.
    Wang CH; Zhu XD; Ma DN; Sun HC; Gao DM; Zhang N; Qin CD; Zhang YY; Ye BG; Cai H; Shi WK; Cao MQ; Tang ZY
    Am J Cancer Res; 2017; 7(5):1068-1083. PubMed ID: 28560058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in gastric cancer.
    Yamanoi K; Fukuma M; Uchida H; Kushima R; Yamazaki K; Katai H; Kanai Y; Sakamoto M
    Pathol Int; 2013 Jan; 63(1):13-9. PubMed ID: 23356221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
    Yu L; Mao X; Wu S; Zhou L; Song W; Gong X; Wang D
    Int J Clin Exp Pathol; 2019; 12(1):327-336. PubMed ID: 31933749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.
    Chen WW; Wang F; Zhang DS; Luo HY; Wang ZQ; Wang FH; Qiu MZ; Ren C; Wei XL; Wu WJ; Li YH; Xu RH
    BMC Cancer; 2014 Mar; 14():222. PubMed ID: 24666414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.